Viewing Study NCT03914794


Ignite Creation Date: 2025-12-25 @ 1:37 AM
Ignite Modification Date: 2026-03-05 @ 2:31 PM
Study NCT ID: NCT03914794
Status: COMPLETED
Last Update Posted: 2025-10-03
First Post: 2019-04-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module